ADAGE CAPITAL PARTNERS GP, L.L.C. - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$4,156,000
-87.8%
562,361
-89.4%
0.01%
-88.0%
Q1 2016$33,946,000
-3.2%
5,312,361
-5.3%
0.09%0.0%
Q4 2015$35,077,000
-14.2%
5,612,361
-19.8%
0.09%
-18.6%
Q3 2015$40,880,000
-26.8%
7,000,000
+3.7%
0.11%
-18.7%
Q2 2015$55,823,000
-8.5%
6,750,000
-8.8%
0.14%
-6.7%
Q1 2015$60,976,000
+6.5%
7,400,000
-11.2%
0.15%
+6.4%
Q4 2014$57,234,000
+13.6%
8,331,000
-10.7%
0.14%
+12.0%
Q3 2014$50,387,000
-0.7%
9,331,000
+17.1%
0.12%
-4.6%
Q2 2014$50,762,000
-5.6%
7,968,993
+19.5%
0.13%
-10.9%
Q1 2014$53,752,000
+125.2%
6,668,993
+90.5%
0.15%
+133.3%
Q4 2013$23,870,000
+21.2%
3,500,000
+226.9%
0.06%
+10.5%
Q3 2013$19,702,000
-57.0%
1,070,752
-59.1%
0.06%
-59.6%
Q2 2013$45,837,000
-6.0%
2,620,752
-2.9%
0.14%
-12.4%
Q1 2013$48,785,0002,698,2720.16%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$94,961,00026.95%
Consonance Capital Management LP 8,845,742$65,370,0009.25%
Opaleye Management Inc. 1,250,000$9,238,0006.17%
Tamarack Advisers, LP 2,100,000$15,519,0005.95%
IRONWOOD INVESTMENT MANAGEMENT LLC 293,352$2,168,0001.62%
Camber Capital Management LP 4,000,000$29,560,0001.43%
Palo Alto Investors LP 2,535,117$18,735,0001.42%
Granite Point Capital Management, L.P. 430,890$3,184,0001.37%
1492 Capital Management LLC 202,500$1,496,0001.34%
HighVista Strategies LLC 869,100$6,423,0001.23%
View complete list of ARIAD PHARMACEUTICALS INC shareholders